Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer
about
Tumor metastasis to boneRNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivoAdhesion rings surround invadopodia and promote maturation.Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics datacisASE: a likelihood-based method for detecting putative cis-regulated allele-specific expression in RNA sequencing data.Identification of tumor markers using two-dimensional electrophoresis in gastric carcinoma.Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process.Mechanics, malignancy, and metastasis: the force journey of a tumor cellSignificance of talin in cancer progression and metastasis.Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Computational identification of surrogate genes for prostate cancer phases using machine learning and molecular network analysis.Activation of Rap1 promotes prostate cancer metastasisThe desmosomal armadillo protein plakoglobin regulates prostate cancer cell adhesion and motility through vitronectin-dependent Src signalingMethylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation.Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.Profiling influences of senescent and aged fibroblasts on prostate carcinogenesisProstate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease.Ultrasound-Mediated Mesenchymal Stem Cells Transfection as a Targeted Cancer Therapy Platform.Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.Steps in prostate cancer progression that lead to bone metastasisGAP-independent functions of DLC1 in metastasis.Priming Endothelial Cells With a Melanoma-Derived Extracellular Matrix Triggers the Activation of αvβ3/VEGFR2 Axis.Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology.Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.Reduced growth and integrin expression of prostate cells cultured with lycopene, vitamin E and fish oil in vitro.Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium.Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer.MET Activation and Physical Dynamics of the Metastatic Process: The Paradigm of Cancers of Unknown Primary Origin.Prostate cancer cells show elevated urokinase receptor in a mouse model of metastasis.Decoupling the effects of stiffness and fiber density on cellular behaviors via an interpenetrating network of gelatin-methacrylate and collagen.Contribution of Adipose Tissue to Development of Cancer.Identification of differential expression lncRNAs in gastric cancer using transcriptome sequencing and bioinformatics analyses.Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma.AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.Breast cancer brain metastasis: molecular mechanisms and directions for treatment
P2860
Q21195416-2F43A7B2-2E2B-4E71-ACD4-FC91FF916152Q24539093-19B92506-0B5F-4353-846F-B662D6E81C1AQ30528643-5BB92213-1E15-4458-8CB6-E4C4CF2EFE83Q30541198-19F1FE0F-918E-4798-BF57-75BDBD226CC6Q31070165-7E4C41F1-A148-4A5F-B577-0AAC2AA55B3DQ31114546-1948A198-0B0D-4AB9-9276-BD0134E90005Q33204842-3DFE1669-52F9-499D-AB1F-C547BA4E2280Q33281964-75BEDAAE-0F53-4A02-B6E3-615BE139D1E6Q33400987-4C7A7D6B-8D01-43D7-B200-B7538D0DEE05Q33763551-C3BF8464-7005-4307-87F2-E3CACFBB966EQ34014559-9257D07C-4E80-45E5-9261-03AA41576C57Q34155176-CC0927F1-2FA5-445F-81FB-D8800F9E4C7EQ34332836-AAE04656-70B5-4B7D-978E-833CBC2D13C3Q34364523-E245A95A-CAB9-495D-9DFE-82AF41040F18Q35572461-3522E589-5E06-4BC3-886D-CF430587A03AQ35699282-88D96A39-8FB6-4C06-8AFC-04A17E5AE118Q36166788-ED0F9BD8-787D-440F-A17B-BA4EBAE48E7FQ36302249-54B132DE-D86B-4B7E-B0B2-ADD14F6D4FE8Q36739411-3984753D-A3C7-4F8E-BA97-BE00879EF4B8Q37053539-5C409540-4F60-41B3-9142-DE72D4FD9CF0Q37365541-74382515-6E8E-4DDC-A33B-BA961FFE3CBFQ37464897-EFFE8A4C-7148-4738-B061-DA5FBB7DAA63Q37627675-837913A5-887D-45BD-8E92-9E18127561BBQ37824564-D1252149-A8AA-49D3-B3DB-6B17880C0AA8Q37848782-0E29C641-A9E0-4758-ACA1-0696C38218BEQ38171331-2F785704-9A39-4E14-9C85-15F2638077D9Q38758000-FC3A9A47-8195-4D87-AE8B-6E20DF3E6155Q39210166-928A58BE-81A5-44B7-A51E-30A5EACD4A79Q39333465-E9FEE3BE-B8F6-4878-8D2A-A0AF2C9DD0DCQ39948673-E5AEAF75-C08D-4041-B8FE-C0C16A9D96CAQ41814914-5C6763F0-2441-4ECB-BAA8-1BD057A07156Q42141004-9854B1C2-58DD-4F00-B3D1-4C0573EA5C44Q42650625-3D132EC9-449B-46CA-8A60-02AC463B5D09Q43097641-8AB651D8-F368-4F3C-8BC0-20DC86E3BD62Q47952724-8DED9239-EC3C-4453-BFEB-410AE83709FAQ49164235-6C1CD5AC-C5A3-4FDD-BBA2-6DC18722831FQ52564099-F79B90EF-0CC8-46BF-B85B-30296CDCDFFDQ55195821-AA4DAD87-7CFB-4DF7-8400-2E93A2DB0F67Q55285081-AA3EBC67-7C33-45AC-AA5D-BB4625E23C40Q57291657-17B31AE0-8CDB-49BB-937B-F5AD3BB1465F
P2860
Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Changes in extracellular matri ...... progression of prostate cancer
@ast
Changes in extracellular matri ...... progression of prostate cancer
@en
Changes in extracellular matri ...... progression of prostate cancer
@nl
type
label
Changes in extracellular matri ...... progression of prostate cancer
@ast
Changes in extracellular matri ...... progression of prostate cancer
@en
Changes in extracellular matri ...... progression of prostate cancer
@nl
prefLabel
Changes in extracellular matri ...... progression of prostate cancer
@ast
Changes in extracellular matri ...... progression of prostate cancer
@en
Changes in extracellular matri ...... progression of prostate cancer
@nl
P2093
P2860
P921
P356
P1476
Changes in extracellular matri ...... progression of prostate cancer
@en
P2093
Carlton R Cooper
Delisha A Stewart
Robert A Sikes
P2860
P2888
P356
10.1186/1477-7827-2-2
P407
P577
2004-01-07T00:00:00Z
P5875
P6179
1053530795